Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Wellesley Investment Advisors
Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Wellesley Investment Advisors
from 13F filings
Historical chart of Wellesley Investment Advisors investment in Sarepta Therapeutics Inc Note 1.250 9/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Wellesley Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Wellesley Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.0B | 2.7M | 1104.43 |
| 2024-09-30 | $2.3B | 2.0M | 1137.97 |
| 2024-06-30 | $2.9B | 2.6M | 1135.86 |
| 2024-03-31 | $2.7B | 2.3M | 1170.37 |
| 2023-12-31 | $2.8B | 2.8M | 1004.84 |
More positions owned by Wellesley Investment Advisors
View all positions for Wellesley Investment Advisors
Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1
View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1